Literature DB >> 3617154

Effect of trimethoprim on serum creatinine in healthy and chronic renal failure volunteers.

S A Myre, J McCann, M R First, R J Cluxton.   

Abstract

The effect of trimethoprim (TMP) on serum creatinine concentration (SCr) was studied in 10 healthy (H) subjects and nine subjects with chronic renal failure (CRF). Each volunteer was given TMP 100 mg perorally every 12 h for 10 days followed by a 7-day washout period. SCr was measured colorimetrically immediately before the study (baseline), on day 10 of TMP, and 7 days after TMP had been discontinued. SCr increased an average of 14.8% from baseline during TMP administration in the H volunteers, but this increase was not statistically significant. During TMP administration to the CRF volunteers, a pronounced elevation (34.6%) of mean SCr from baseline was observed (p less than 0.05). SCr returned to baseline values in both groups following the 7-day washout period. These results are consistent with the hypothesis that TMP competitively inhibits the renal tubular secretion of creatinine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3617154     DOI: 10.1097/00007691-198706000-00006

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  12 in total

1.  Effects of moderate-dose versus high-dose trimethoprim on serum creatinine and creatinine clearance and adverse reactions.

Authors:  O Naderer; A N Nafziger; J S Bertino
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

2.  Chronic kidney disease and estimates of kidney function in HIV infection: a cross-sectional study in the multicenter AIDS cohort study.

Authors:  Michelle M Estrella; Rulan S Parekh; Brad C Astor; Robert Bolan; Rhobert W Evans; Frank J Palella; Lisa P Jacobson
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08-15       Impact factor: 3.731

3.  Hyperkalaemia and non-oliguric renal failure associated with trimethoprim.

Authors:  G W Smith; S B Cohen
Journal:  BMJ       Date:  1994-02-12

4.  Drug-induced reduction in estimated glomerular filtration rate in patients with ALK-positive non-small cell lung cancer treated with the ALK inhibitor crizotinib.

Authors:  Evelyn M Brosnan; Andrew J Weickhardt; Xian Lu; Delee A Maxon; Anna E Barón; Michel Chonchol; D Ross Camidge
Journal:  Cancer       Date:  2013-11-20       Impact factor: 6.860

5.  Chelidonium majus leaves methanol extract and its chelidonine alkaloid ingredient reduce cadmium-induced nephrotoxicity in rats.

Authors:  Khaled M M Koriem; Mahmoud S Arbid; Gihan F Asaad
Journal:  J Nat Med       Date:  2012-04-08       Impact factor: 2.343

Review 6.  The renal effects of ALK inhibitors.

Authors:  Hassan Izzedine; Rania Kheder El-Fekih; Mark A Perazella
Journal:  Invest New Drugs       Date:  2016-07-29       Impact factor: 3.850

7.  The MDRD equation predicts peritoneal dialysis-delivered creatinine clearances from serum creatinine.

Authors:  Nitin Khosla; Robert W Steiner
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-01       Impact factor: 8.237

8.  The effect of acyclovir on the tubular secretion of creatinine in vitro.

Authors:  Patrina Gunness; Katarina Aleksa; Gideon Koren
Journal:  J Transl Med       Date:  2010-12-30       Impact factor: 5.531

Review 9.  Individualizing pharmacotherapy in patients with renal impairment: the validity of the Modification of Diet in Renal Disease formula in specific patient populations with a glomerular filtration rate below 60 ml/min. A systematic review.

Authors:  Willemijn L Eppenga; Cornelis Kramers; Hieronymus J Derijks; Michel Wensing; Jack F M Wetzels; Peter A G M De Smet
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

10.  Fluctuation of the renal function after discharge from hospital and its effects on drug dosing in elderly patients--study protocol.

Authors:  Willemijn L Eppenga; Wietske N Wester; Hieronymus J Derijks; Rein M J Hoedemakers; Michel Wensing; Peter A G M De Smet; Rob J Van Marum
Journal:  BMC Nephrol       Date:  2015-07-07       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.